Xtandi
NDC 0469-0125, enzalutamide, capsule, from Astellas Pharma US, Inc..
- Product NDC
- 0469-0125
- Status
- Listed
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203415
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0469-0125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENZALUTAMIDE40 mg/1
Pharmacologic classes
Androgen Receptor Antagonists [MoA]; Androgen Receptor Inhibitor [EPC]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0469-0125-99 | 00469012599 | 1 BOTTLE in 1 CARTON (0469-0125-99) / 120 CAPSULE in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf
Use it
Look up 0469-0125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0469-0125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0469-0125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.